Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer [Phase 2]
A phase 2 study evaluating the combination of RAD001 (everolimus) and bevacizumab in recurrent ovarian, fallopian tube, and primary peritone…
-
CLINICAL_TRIALS withdrawal · 2016-08-30Clinical Trial Update: Effects of Gum Chewing on Recovery of Bowel Function Following Abdominal Surgery for Endometrial and Ovarian Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating gum chewing to accelerate recovery of bowel function after abdominal surgery for endometrial and ovari…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Tivozanib As Maintenance Therapy In GYN [Phase 2]
Phase 2 trial evaluating tivozanib as maintenance therapy in gynecologic cancers was terminated, with results posted in 2016.
-
FDA approval · 2016-08-23FDA Approved: PACLITAXEL PACLITAXEL — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved the original application for a generic paclitaxel product, manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmac…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma [Phase 2]
Phase 2 trial evaluating carboplatin plus docetaxel with day 2 pegfilgrastim (Neulasta) in advanced ovarian carcinoma was terminated; result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-08-17Clinical Trial Update: Institut Paoli Calmettes Ovarian Cancer Database
A recruiting clinical trial sponsored by Institut Paoli-Calmettes concerns an ovarian cancer database. The study is currently in the recruit…
-
CLINICAL_TRIALS research · 2016-08-17Clinical Trial Update: Genetic Counseling in African American Women [NA]
This update notes the completion of a clinical trial at the University of Pennsylvania evaluating genetic counseling in African American wom…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Catumaxomab as a Consolidation Therapy in Patients With Ovarian Cancer in Second or Third Clinical Disease Remission [Phase 2]
A Phase 2 trial evaluating catumaxomab as consolidation therapy for ovarian cancer patients in second or third clinical remission has comple…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer [Phase 2]
Phase 2 trial investigating pazopanib for platinum-resistant advanced ovarian cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2016-08-10Clinical Trial Update: LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma [Phase 1]
A Phase 1 trial evaluating LDFWART in combination with docetaxel for platinum-resistant recurrent ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2016-08-10Clinical Trial Update: Intra-peritoneal Chemotherapy in Ovarian Cancer
An update on a clinical trial studying intra-peritoneal chemotherapy for ovarian cancer, sponsored by Radboud University Medical Center. The…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum Chemotherapy [Phase 1]
A Phase 1 trial of a viral therapy in patients with recurrent fallopian tube cancer, recurrent ovarian cancer, or recurrent primary peritone…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer
A completed clinical trial investigates preoperative predictors that may determine the likelihood of achieving optimal cytoreductive surgery…
-
CLINICAL_TRIALS research · 2016-08-04Clinical Trial Update: Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)
This completed clinical trial evaluated attitudes toward childbearing and fertility among individuals with inherited breast and ovarian canc…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies [Phase 1]
Phase 1 study of T cell receptor-transduced T cells targeting NY-ESO-1 in patients with NY-ESO-1-expressing malignancies to assess safety an…
-
CLINICAL_TRIALS withdrawal · 2016-07-26Clinical Trial Update: Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer [Phase 1]
A Phase 1 trial of talazoparib in combination with the HSP90 inhibitor AT13387 for metastatic advanced solid tumors and recurrent ovarian, f…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer [Phase 3]
Phase III trial OVATURE comparing weekly carboplatin with and without phenoxodiol in platinum-resistant recurrent epithelial ovarian cancer …
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
A completed Phase 1/Phase 2 study evaluating phenoxodiol in combination with cisplatin or paclitaxel for recurrent ovarian epithelial, fallo…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors
The Children's Oncology Group conducted a gene-focused study on tissue samples from younger patients with ovarian or testicular sex cord str…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis [Phase 3]
Phase 3 trial evaluating octreotide to prevent diarrhea in patients receiving pelvic radiotherapy across multiple pelvic cancers has complet…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Tumor Gene Expression in Women With Ovarian Cancer [Phase 4]
Phase 4 clinical trial update on tumor gene expression in women with ovarian cancer; results were posted on 2016-07-13. The study reports la…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase II trial results for MK-2206, an Akt inhibitor, in recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer …
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 trial evaluating UCN-01 in combination with topotecan in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, o…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors [Phase 2]
Phase 2 trial evaluating combination chemotherapy with peripheral stem cell transplantation for germ cell tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer [Phase 1]
This clinical trial update describes a Phase I study of low-dose Whole Abdominal Radiation Therapy (WART) in combination with weekly paclita…